Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 4/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.49 |
| ▸ | MAPT | P10636 | 3/20 | 0.49 |
| ▸ | POLB | P06746 | 2/20 | 0.49 |
| ▸ | NPC1 | O15118 | 2/20 | 0.49 |
| ▸ | RAB9A | P51151 | 2/20 | 0.49 |
| ▸ | CDK4 | P11802 | 2/20 | 0.47 |
| ▸ | CCND1 | P24385 | 2/20 | 0.47 |
| ▸ | GAA | P10253 | 2/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | PKM | P14618 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | BLM | P54132 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.45 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26479058 | 0.90 | POLB (0.47) | MEN1KMT2AMAPTPOLBNPC1 | |
| SCHEMBL26479259 | 0.86 | POLB (0.46) | MEN1KMT2AMAPTPOLBNPC1 | |
| SCHEMBL31066851 | 0.86 | POLB (0.45) | MEN1KMT2AMAPTPOLBNPC1 | |
| Potassium Ion SCHEMBL31066852 | 0.86 | POLB (0.45) | MEN1KMT2AMAPTPOLBNPC1 | |
| SCHEMBL26479248 | 0.83 | HTR2A (0.41) | MEN1KMT2AMAPTPOLBNPC1 | |
| SCHEMBL31066841 | 0.82 | POLB (0.41) | MEN1KMT2AMAPTPOLBNPC1 | |
| SCHEMBL31066853 | 0.80 | TRPV1 (0.41) | MEN1KMT2AMAPTPOLBNPC1 | |
| SCHEMBL26479105 | 0.78 | HTR2A (0.54) | MEN1KMT2AMAPTPOLBGAA | |
| SCHEMBL31066855 | 0.78 | KMT2A (0.43) | MEN1KMT2AMAPTPOLBRAB9A | |
| SCHEMBL4317964 | 0.78 | ALDH1A1 (0.54) | MEN1KMT2AMAPTNPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230357146-A1 | PRODRUGS AND CONJUGATES OF DIMETHYLTRYPTAMINE | ATAI THERAPEUTICS, INC. | 2023-11-09 | — | — | US | disclosed |
| US-11643391-B2 | Prodrugs and conjugates of dimethyltryptamine | ATAI THERAPEUTICS, INC. | 2023-05-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230357146-A1 | PRODRUGS AND CONJUGATES OF DIMETHYLTRYPTAMINE | NPY1R, NPY5R, NPY2R | MEN1 495/4885KMT2A 662/4885MAPT 1338/4885 |
| US-11643391-B2 | Prodrugs and conjugates of dimethyltryptamine | NPY1R, NPY5R, NPY2R | MEN1 495/4885KMT2A 662/4885MAPT 1338/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.